A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Dry Eye Disease
Interventions
DRUG

Carboxymethylcellulose Based Eye Drop Formulation A

Carboxymethylcellulose Based Eye Drop Formulation A 1-2 drops in each eye as needed at least 2 times daily for 90 days.

DRUG

Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops

Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops (OPTIVE™) 1-2 drops in each eye as needed at least 2 times daily for 90 days.

Trial Locations (12)

Unknown

Randwick

Leuven

Marseille

Tours

Freiburg im Breisgau

Padua

Parma

Moscow

Huelva

Valencia

Southampton

Great Yarmouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY